Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma (clinicaltrials.gov) - Jul 12, 2025 - P1 | N=56 | Not yet recruiting | Sponsor: Plus Therapeutics
New P1 trial • Brain Cancer • Ependymoma • Glioma • High Grade Glioma • Oncology • Pediatrics • Solid Tumor
|